AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Trimegabose 1mg/500mg/0.2mg Tablet

Prescription Icon
Prescription Required

Marketer

Aristo Pharmaceuticals Pvt Ltd

Salt Composition

Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.2mg)

Overview Trimegabose 1mg/500mg/0.2mg Tablet

Diabetol Trio 1 mg/500 mg/0.2 mg tablets are classified as anti-diabetic medications. This combination therapy is indicated for adult patients with type 2 diabetes mellitus to manage blood glucose levels. Diabetol Trio should be ingested with food, consistently at the same time daily for optimal efficacy. Dosage is determined and adjusted by your physician based on your blood sugar response. Continuous use is crucial; discontinuation without medical consultation risks elevated blood sugar, potentially leading to kidney complications, vision loss, neuropathy, and limb amputation. Remember, this medication complements a comprehensive diabetes management plan encompassing diet, exercise, and weight management as recommended by your doctor. Lifestyle modifications are essential for diabetes control. Hypoglycemia (low blood sugar) is a common adverse effect, characterized by symptoms like sweating, dizziness, headache, and tremors. Learn to identify and manage these symptoms; maintain regular meals and carry a readily available fast-acting glucose source, such as sweets or juice. Alcohol consumption should be limited due to its potential to exacerbate hypoglycemia. Additional potential side effects include altered taste, nausea, diarrhea, abdominal pain, headache, edema, blurred vision, bone fractures, and upper respiratory infections. Weight gain may also occur. This medication is contraindicated in patients with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before initiating treatment. Pregnant or lactating individuals require medical consultation before use. Regular blood glucose monitoring is necessary, and your doctor may order blood tests to track blood cell counts and liver function.

Primary Ingredients of Trimegabose 1mg/500mg/0.2mg Tablet

No text provided to rephrase.

Uses of Trimegabose 1mg/500mg/0.2mg Tablet

Managing type 2 diabetes

Major Benefits of Trimegabose 1mg/500mg/0.2mg Tablet:

Consume this medication precisely as directed by your physician, adhering to both the prescribed dosage and duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Trimegabose 1 mg/500 mg/0.2 mg Tablet on an empty stomach.

Common Side effects of Trimegabose 1mg/500mg/0.2mg Tablet:

  • Nausea
  • Diarrhea
  • Abdominal pain
  • Hypoglycemia (low blood glucose level)
  • Loss of appetite

How to use Trimegabose 1mg/500mg/0.2mg Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Trimegabose 1 mg/500 mg/0.2 mg Tablet whole; do not break, crush, or chew it. Administer on an empty stomach.

How Trimegabose 1mg/500mg/0.2mg Tablet works:

Each Trimegabose tablet (1 mg/500 mg/0.2 mg) contains a triple-action blend of antidiabetic agents.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Trimegabose 1 mg/500 mg/0.2 mg tablets with alcohol is not advisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Trimegabose 1 mg/500 mg/0.2 mg Tablet during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible dangers prior to prescribing. Physician consultation is advised.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Trimegabose 1 mg/500 mg/0.2 mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyUNSAFE

Patients with kidney disease should likely avoid Trimegabose 1 mg/500 mg/0.2 mg Tablets due to potential safety concerns. Medical advice is recommended. The use of Trimegabose 1 mg/500 mg/0.2 mg Tablets is contraindicated in those with severe kidney impairment.

LiverLiverCAUTION

Patients with liver impairment should use Trimegabose 1 mg/500 mg/0.2 mg tablets cautiously, potentially requiring dosage modification. Consultation with a physician is advised. A low initial dose is typically recommended for those with mild to moderate hepatic dysfunction; the medication is contraindicated in cases of severe liver disease.

What if you forget to take Trimegabose 1mg/500mg/0.2mg Tablet :

Should you forget to take your Trimegabose 1 mg/500 mg/0.2 mg Tablet, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Trimegabose 1mg/500mg/0.2mg Tablet

LabelValue
Potential for Dependence None.
Type of Treatment Diabetes medication

FAQs on Trimegabose 1mg/500mg/0.2mg Tablet

Trimegabose 1 mg/500 mg/0.2 mg tablets contain glimepiride, metformin, and voglibose, working synergistically to manage type 2 diabetes mellitus. This medication aids in blood sugar control in adults when combined with a healthy diet and exercise regimen. Glimepiride stimulates insulin secretion from the pancreas, reducing blood glucose. Metformin decreases hepatic glucose production and enhances insulin responsiveness. Voglibose, an alpha-glucosidase inhibitor, reduces post-meal blood sugar elevation. This formulation is unsuitable for treating type 1 diabetes.
Taking Trimegabose 1 mg/500 mg/0.2 mg Tablets may result in side effects such as low blood sugar, queasiness, loose stools, taste changes, gas, abdominal discomfort, head pain, skin eruptions, and upper respiratory illness.
Patients with hypersensitivity to Trimegabose 1 mg/500 mg/0.2 mg Tablet constituents or inactive ingredients should not take this medication. Its administration is contraindicated in individuals with moderate to severe renal impairment, inflammatory bowel conditions, colonic ulcers, and underlying metabolic acidosis, including diabetic ketoacidosis.
Combining Trimegabose 1 mg/500 mg/0.2 mg tablets and alcohol is unsafe. This combination risks dangerously low blood sugar (hypoglycemia) and raises the probability of lactic acidosis.
Indeed, Trimegabose 1 mg/500 mg/0.2 mg Tablets may induce hypoglycemia. Low blood sugar can manifest as nausea, headache, irritability, hunger, sweating, dizziness, tachycardia, and anxiety or tremors. The risk increases with skipped or delayed meals, alcohol consumption, excessive physical activity, or concomitant use of other antidiabetic medications. Therefore, consistent blood glucose monitoring is crucial. Carrying glucose tablets, honey, or fruit juice is recommended.
Retain this medication within its original, sealed packaging. Follow the storage directions printed on the package or label. Discard any remaining medication. Ensure it remains inaccessible to children, animals, and others.
Trimegabose 1mg/500mg/0.2...
62
MRP 76
17% off